Antimicrobial Resistance: Epidemiology, Drivers, Dynamics, and Control
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Mechanism and Evolution of Antibiotic Resistance".
Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 18525
Special Issue Editor
Special Issue Information
Dear Colleagues,
Antimicrobial resistance (AMR) in bacterial pathogens is a worldwide challenge associated with high morbidity and mortality. In a global report on surveillance in AMR, The World Health Organization (WHO) declared that AMR in a wide range of infectious agents has become a serious public health problem and a post-antibiotic era is a real possibility in the 21st century. Although there are significant gaps in surveillance and a lack of standards for methodologies in many countries worldwide, the WHO reported very high rates of resistance both for health-care associated (HCA) and community-acquired (CA) infections. Fighting this threat is a public health priority that requires a collaborative global approach across sectors.
These resistant bacteria may infect humans and animals, and the infections they cause are harder to treat and are associated with higher medical costs, prolonged hospital stays, and increased morbidity, mortality and lethality.
Society urgently needs to change the way it uses antibiotics. Even if new medicines are developed, without a change in behaviour AMR will remain a major threat. Behavioural changes must also include common actions in our everyday lives (such as hand washing and proper food hygiene).
AMR is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases and a lot of infections are becoming more difficult to treat as antibiotics become less effective.
The main reasons for the increasing incidence of AMR is the unnecessary use of antibiotics for the treatment of viral infections and the misuse and overuse of antibiotics, as well as poor infection prevention and control. Steps can be taken at all levels of society to reduce this threat.
Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries can once again kill.
Prof. Dr. Ondřej Holý
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance
- infectious diseases
- public health
- infection control
- prevention
